Full Press Release Details
Elan to Highlight Tysabri Data in Crohn’s Disease at the American College of Gastroenterology Annual Scientific Meeting.
BIIB
Elan to Highlight Tysabri Data in Crohn’s Disease at the American College of Gastroenterology Annual Scientific Meeting
Key Takeaway: Elan to Highlight Tysabri Data in Crohn’s Disease at the American College of Gastroenterology Annual Scientific Meeting
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis